Previous 10 | Next 10 |
HILLSIDE, NJ / ACCESSWIRE / May 11, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2023. Revenue for the quarter ended March 31, 2023 was $13.1 million compared to $15.6 million for the quarte...
HILLSIDE, NJ / ACCESSWIRE / March 21, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced that Edward G. Kay, the Company's Founder, Executive Chairman and President passed away yesterday evening. Mr. Kay was 86 years old. The Board of Directors issued the followi...
HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022. Revenue for the quarter ended December 31, 2022 was $12.3 million compared to $14.6 million for the quarter e...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Despite warnings, investors still gravitate toward the realm of speculation, thereby necessitating a discussion about the best penny stocks under $1 to buy. To be clear, you don’t want to participate with an...
Integrated BioPharma press release ( OTCQX:INBP ): FQ1 GAAP EPS of $0.00. Revenue of $12.3M (-3.9% Y/Y). For further details see: Integrated BioPharma GAAP EPS of $0.00, revenue of $12.3M
HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022. Revenue for the quarter ended September 30, 2022 was $12.3 million compared to $12.8 million for the quar...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Despite warnings, investors still gravitate toward the realm of speculation, thereby necessitating a discussion about the best penny stocks under $1 to buy. To be clear, you don’t want to participate with any funds w...
Integrated BioPharma press release ( OTCQX:INBP ): Q4 GAAP EPS of $0.05. Revenue of $13.27M (-22.2% Y/Y). "While our revenue decreased by approximately 11.6% in the fiscal year ended June 30, 2022 from the prior fiscal year ended June 30, 2021 our revenue from our two larg...
HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022. Revenue for the quarter ended June 30, 2022 was $13.3 million compared to $17.1 million for t...
HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board of Directors and Mr. Damon DeSantis, has been elected to serve as a Class I Director t...
News, Short Squeeze, Breakout and More Instantly...
Integrated Biopharma Inc Company Name:
INBP Stock Symbol:
OTCMKTS Market:
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the quarter ended December 31, 2023 was $11.5 million compared to $12.3 million for the quarter ...
Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...
HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for the quarter ended September 30, 2023 was $12.9 million compared to $12.3 million for the quarter e...